Search

Author/Creator Diltoer, Marc

2. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Issue 12 (December 2022)

Authors:
Vlaar, Alexander P J; Witzenrath, Martin; van Paassen, Pieter; Heunks, Leo M A; Mourvillier, Bruno; de Bruin, Sanne; Lim, Endry H T; Brouwer, Matthijs C; Tuinman, Pieter R; Saraiva, José F K; Marx, Gernot; Lobo, Suzana M; Boldo, Rodrigo; Simon-Campos, Jesus A; Cornet, Alexander D; Grebenyuk, Anas...
Journal:
Lancet
Issue:
Volume 10:Issue 12(2022)
Page Start:
1137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Issue 10370 (7th January 2023)

Authors:
Thompson, George R; Soriano, Alex; Cornely, Oliver A; Kullberg, Bart Jan; Kollef, Marin; Vazquez, Jose; Honore, Patrick M; Bassetti, Matteo; Pullman, John; Chayakulkeeree, Methee; Poromanski, Ivan; Dignani, Cecilia; Das, Anita F; Sandison, Taylor; Pappas, Peter G; Akova, Murat; AlAgha, Rawan; Ala...
Journal:
Lancet
Issue:
Volume 401:Issue 10370(2023)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗